Overview Ceftobiprole in Hospital Acquired Pneumonia Status: Completed Trial end date: 2007-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia. Phase: Phase 3 Details Lead Sponsor: Basilea PharmaceuticaTreatments: CeftazidimeCeftobiproleCeftobiprole medocarilCephalosporinsLinezolid